Skip to main navigation Skip to search Skip to main content

Genetic changes in breast cancer detected by comparative genomic hybridisation

  • Ruth L. Loveday
  • , John Greenman
  • , Deborah L. Simcox
  • , Valerie Speirs
  • , Philip J. Drew
  • , John R.T. Monson
  • , Michael J. Kerin
  • Castle Hill Hospital
  • University of Hull

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

79 Citations (Scopus)

Abstract

Breast cancer is characterised by a number of genetic aberrations. Our purpose was to use comparative genomic hybridisation (CGH) to screen breast carcinomas for copy number changes: 44 ductal and 8 lobular carcinomas were studied and a marge number of genetic aberrations identified. Many of these showed similarity to previous CGH results, however, a number of loci not previously shown to have undergone frequent change were identified. This included copy number gains affecting chromosomes 1p, 4q, 5q, 6q and 13q. Furthermore, we have identified 2 regions of copy number change, the gain on 5p and deletion of 16q, which correlated with lobular carcinomas. Our results highlight several areas of the genome that may be important in the molecular genetics of breast cancer. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)494-500
Number of pages7
JournalInternational Journal of Cancer
Volume86
Issue number4
DOIs
Publication statusPublished - 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genetic changes in breast cancer detected by comparative genomic hybridisation'. Together they form a unique fingerprint.

Cite this